(Q54394384)

29 May 2018

title

Proliferative response of lymphocytes from ovarian cancer patients to autologous tumor cells. (English)

1 reference

29 May 2018

1 reference

8

1 reference

29 May 2018

author name string

P Allavena

1

1 reference

29 May 2018

P Lo Presti

2

1 reference

29 May 2018

M Di Bello

3

1 reference

29 May 2018

V Lucchini

4

1 reference

29 May 2018

A Lissoni

5

1 reference

29 May 2018

G Zanetta

6

1 reference

29 May 2018

C Mangioni

7

1 reference

29 May 2018

publication date

1 January 1988

1 reference

29 May 2018

Cancer Immunology, Immunotherapy

published in

1 reference

29 May 2018

volume

27

1 reference

29 May 2018

issue

1

1 reference

29 May 2018

page(s)

69-76

1 reference

29 May 2018

https://scigraph.springernature.com/pub.10.1007/bf00205761

exact match

0 references

cites work

Clonal analysis of T lymphocytes isolated from ovarian carcinoma ascitic fluid. Phenotypic and functional characterization of T-cell clones capable of lysing autologous carcinoma cells

1 reference

12 December 2020

Tumoricidal activity of macrophages isolated from human ascitic and solid ovarian carcinomas: augmentation by interferon, lymphokines and endotoxin

1 reference

12 December 2020

Correlation between lymphocyte-mediated auto-tumor reactivities and clinical course. I. Evaluation of 46 patients with sarcoma

1 reference

12 December 2020

Lymphocyte cytotoxicity against autologous tumour biopsy cells in humans.

1 reference

12 December 2020

Tumor-specific transplantation antigens: G. H. A. Clowes memorial lecture

1 reference

12 December 2020

Activation of peritoneal lymphocyte cytotoxicity in patients with ovarian cancer by intraperitoneal treatment with Corynebacterium parvum

1 reference

12 December 2020

The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells

1 reference

12 December 2020

Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response

1 reference

12 December 2020

Quantitation of proliferative and cytotoxic precursor cells directed against human tumours: limiting dilution analysis in peripheral blood and at the tumour site

1 reference

12 December 2020

Cancer immunology: the search for specificity--G. H. A. Clowes Memorial lecture

1 reference

12 December 2020

Mononuclear-cell infiltration in ovarian cancer. II. Immune function of tumour and ascites-derived inflammatory cells

1 reference

12 December 2020

Therapy of disseminated murine leukemia with cyclophosphamide and immune Lyt-1+,2- T cells. Tumor eradication does not require participation of cytotoxic T cells

1 reference

12 December 2020

DR antigens expressed on tumor cells do not contribute to the blastogenetic response of autologous T cells

1 reference

12 December 2020

Intraperitoneal administration of interferon beta in ovarian cancer patients

1 reference

12 December 2020

Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity

1 reference

12 December 2020

Lymphocyte cytotoxicity in the peritoneal cavity and blood of patients with ovarian cancer

1 reference

12 December 2020

Natural killer cell cytotoxic potential of patients with ovarian carcinoma and its modulation with virus-modified tumor cell extract

1 reference

12 December 2020

Interferon effect on cytotoxicity of peripheral blood and tumor-associated lymphocytes against human ovarian carcinoma cells

1 reference

12 December 2020

Suppression of the responsiveness of lymphocytes from cancer patients triggered by co-culture with autologous tumor-derived cells

1 reference

12 December 2020

The human mixed lymphocyte-tumor cell interaction test. I. Positive autologous lymphocyte proliferative responses can be stimulated by tumor cells as well as by cells from normal tissues.

1 reference

12 December 2020

Interleukin 2 activated tumor inhibition in vivo depends on the systemic involvement of host immunoreactivity

1 reference

12 December 2020

Cloning of human lymphocytes reactive with autologous leukemia cells

1 reference

12 December 2020

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

1 reference

12 December 2020

Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes

1 reference

12 December 2020

Correlation between lymphocyte-mediated auto-tumor reactivities and the clinical course. II. Evaluation of 69 patients with lung carcinoma

1 reference

12 December 2020

Tumour-reactive lymphocytes stimulated in mixed lymphocyte and tumour culture. Clonal analysis of effector cells in cytotoxic and proliferative assays

1 reference

12 December 2020

Lymphokine-activated killer activity of tumor-associated and peripheral blood lymphocytes isolated from patients with ascites ovarian tumors

1 reference

12 December 2020

Antigenic properties of methylcholanthrene-induced tumors in mice of the strain of origin

1 reference

12 December 2020

Human tumor-lymphocyte interactionin vitro. III. T lymphocytes in autologous tumor stimulation (ATS)

1 reference

12 December 2020

Intraperitoneal administration ofcorynebacterium parvum in patients with ascitic ovarian tumors resistant to chemotherapy: Effects on cytotoxicity of tumor-associated macrophages and NK cells

1 reference

12 December 2020

Human tumour antigens defined by cytotoxicity and proliferative responses of cultured lymphoid cells

1 reference

12 December 2020

Primary but not metastatic human melanomas expressing dr antigens stimulate autologous lymphocytes

1 reference

12 December 2020

Natural killer activity of lymphoid cells isolated from human ascitic ovarian tumors

1 reference

12 December 2020

Intraperitoneal recombinant alpha-interferon for "salvage" immunotherapy in stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00205761

1 reference

29 May 2018

PubMed ID

2969284

1 reference

29 May 2018